MindSense

Company Overview

Snapshot

Founded in January 2021 by Shlomo Mendlovic, Mor Bar, and Udi Bobrovsky, MindSense operates with 1–10 employees. The company secured one funding round in August 2021. MindSense ceased operations in January 2022.

Business overview

MindSense is a deep-technology psychotherapy company that leverages AI and evidence-based research to provide meaningful insights for therapy sessions. Its platform decodes therapy interactions into measurable data points, enabling therapists to track outcomes and actively manage treatment. The company's proprietary AI technology translates statements into data and summarizes sessions with objective, personalized guidance. MindSense operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers in markets such as North America, Denmark, Germany, and the United Kingdom.

Company Intelligence Q&A

What is MindSense's core technology?

MindSense utilizes proprietary AI technology, including machine learning and natural language processing, to analyze therapy sessions and provide measurable insights and personalized feedback to therapists.

When was MindSense founded?

MindSense was founded in January 2021.

What is the primary mission of MindSense?

MindSense's mission is to help therapists improve their therapy practices and deliver better care by providing tools to measure outcomes and manage psychotherapy treatment effectively.

What is the operational status of MindSense?

MindSense ceased to operate in January 2022.

Which markets does MindSense target?

MindSense targets geomarkets including North America, Denmark, Germany, and the United Kingdom.